Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-21

Clinical Trial Update: The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study [Phase 2]

View source ↗

Summary

Phase 2 study evaluating caffeine to prevent or reduce postoperative delirium and postoperative cognitive dysfunction after surgery; status is active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: University of Michigan | Conditions: Postoperative Delirium, Postoperative Cognitive Dysfunction | Phase 2 | Status: ACTIVE_NOT_RECRUITING